Annual Revenue
$63.71 M
+$24.22 M+61.32%
December 31, 2024
Summary
- As of March 13, 2025, VIR annual revenue is $63.71 million, with the most recent change of +$24.22 million (+61.32%) on December 31, 2024.
- During the last 3 years, VIR annual revenue has fallen by -$1.02 billion (-94.14%).
- VIR annual revenue is now -95.97% below its all-time high of $1.58 billion, reached on December 31, 2022.
Performance
VIR Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$11.28 M
+$10.99 M+3802.42%
December 31, 2024
Summary
- As of March 13, 2025, VIR quarterly revenue is $11.28 million, with the most recent change of +$10.99 million (+3802.42%) on December 31, 2024.
- Over the past year, VIR quarterly revenue has increased by +$10.34 million (+1098.51%).
- VIR quarterly revenue is now -99.08% below its all-time high of $1.23 billion, reached on March 31, 2022.
Performance
VIR Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$63.71 M
+$1.68 M+2.70%
December 31, 2024
Summary
- As of March 13, 2025, VIR TTM revenue is $63.71 million, with the most recent change of +$1.68 million (+2.70%) on December 31, 2024.
- Over the past year, VIR TTM revenue has increased by +$6.06 million (+10.52%).
- VIR TTM revenue is now -97.31% below its all-time high of $2.37 billion, reached on September 30, 2022.
Performance
VIR TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
VIR Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +61.3% | +1098.5% | +10.5% |
| 3 y3 years | -94.1% | -75.9% | -84.0% |
| 5 y5 years | +8860.9% | -75.9% | -84.0% |
VIR Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -96.0% | +61.3% | -99.1% | +126.4% | -97.3% | +61.3% |
| 5 y | 5-year | -96.0% | +8860.9% | -99.1% | +126.4% | -97.3% | +8860.9% |
| alltime | all time | -96.0% | >+9999.0% | -99.1% | +126.4% | -97.3% | >+9999.0% |
Vir Biotechnology Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $63.71 M(+61.3%) | $11.28 M(+3802.4%) | $63.71 M(+2.7%) |
| Sep 2024 | - | $289.00 K(-69.3%) | $62.04 M(+7.6%) |
| Jun 2024 | - | $941.00 K(-98.2%) | $57.65 M(+31.1%) |
| Mar 2024 | - | $51.20 M(+433.3%) | $43.99 M(+11.4%) |
| Dec 2023 | $39.49 M(-97.5%) | $9.60 M(-334.3%) | $39.49 M(-23.6%) |
| Sep 2023 | - | -$4.10 M(-67.8%) | $51.68 M(-87.9%) |
| Jun 2023 | - | -$12.72 M(-127.2%) | $427.21 M(+7.5%) |
| Mar 2023 | - | $46.71 M(+114.4%) | $397.25 M(-74.9%) |
| Dec 2022 | $1.58 B(+45.4%) | $21.79 M(-94.1%) | $1.58 B(-33.3%) |
| Sep 2022 | - | $371.43 M(-970.1%) | $2.37 B(+12.8%) |
| Jun 2022 | - | -$42.69 M(-103.5%) | $2.10 B(-9.4%) |
| Mar 2022 | - | $1.23 B(+51.9%) | $2.32 B(+113.1%) |
| Dec 2021 | $1.09 B | $809.76 M(+688.4%) | $1.09 B(+291.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $102.71 M(-41.0%) | $277.61 M(+58.6%) |
| Jun 2021 | - | $173.99 M(>+9900.0%) | $175.08 M(+159.9%) |
| Mar 2021 | - | $605.00 K(+101.0%) | $67.36 M(+0.2%) |
| Dec 2020 | $67.25 M(+9357.8%) | $301.00 K(+60.1%) | $67.25 M(-0.1%) |
| Sep 2020 | - | $188.00 K(-99.7%) | $67.31 M(-0.1%) |
| Jun 2020 | - | $66.27 M(>+9900.0%) | $67.36 M(+5604.0%) |
| Mar 2020 | - | $487.00 K(+31.3%) | $1.18 M(+66.1%) |
| Dec 2019 | $711.00 K(-18.1%) | $371.00 K(+56.5%) | $711.00 K(+105.5%) |
| Sep 2019 | - | $237.00 K(+175.6%) | $346.00 K(+55.2%) |
| Jun 2019 | - | $86.00 K(+405.9%) | $223.00 K(+62.8%) |
| Mar 2019 | - | $17.00 K(+183.3%) | $137.00 K(+14.2%) |
| Dec 2018 | $868.00 K(+482.6%) | $6000.00(-94.7%) | $120.00 K(+5.3%) |
| Sep 2018 | - | $114.00 K | $114.00 K |
| Dec 2017 | $149.00 K | - | - |
FAQ
- What is Vir Biotechnology annual revenue?
- What is the all time high annual revenue for Vir Biotechnology?
- What is Vir Biotechnology annual revenue year-on-year change?
- What is Vir Biotechnology quarterly revenue?
- What is the all time high quarterly revenue for Vir Biotechnology?
- What is Vir Biotechnology quarterly revenue year-on-year change?
- What is Vir Biotechnology TTM revenue?
- What is the all time high TTM revenue for Vir Biotechnology?
- What is Vir Biotechnology TTM revenue year-on-year change?
What is Vir Biotechnology annual revenue?
The current annual revenue of VIR is $63.71 M
What is the all time high annual revenue for Vir Biotechnology?
Vir Biotechnology all-time high annual revenue is $1.58 B
What is Vir Biotechnology annual revenue year-on-year change?
Over the past year, VIR annual revenue has changed by +$24.22 M (+61.32%)
What is Vir Biotechnology quarterly revenue?
The current quarterly revenue of VIR is $11.28 M
What is the all time high quarterly revenue for Vir Biotechnology?
Vir Biotechnology all-time high quarterly revenue is $1.23 B
What is Vir Biotechnology quarterly revenue year-on-year change?
Over the past year, VIR quarterly revenue has changed by +$10.34 M (+1098.51%)
What is Vir Biotechnology TTM revenue?
The current TTM revenue of VIR is $63.71 M
What is the all time high TTM revenue for Vir Biotechnology?
Vir Biotechnology all-time high TTM revenue is $2.37 B
What is Vir Biotechnology TTM revenue year-on-year change?
Over the past year, VIR TTM revenue has changed by +$6.06 M (+10.52%)